Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Dec
15
2014
Vermont Doubles Down: Representative Testifies Before Congress Against Federal GMO Labeling Bill Mintz
Sep
7
2022
FDA Announces Review of Opioid Prescribing Regulations and Framework for Preventing Overdose-Related Deaths Mintz
Mar
18
2015
Indiana Federal Court Denies Generic Drug Manufacturer’s Motion to Dismiss Hatch-Waxman Patent Infringement Action on Jurisdiction Grounds Mintz
Sep
28
2022
MintzRx — Digital Health Update: Federal Government Shows Growing Enforcement Interest in Online Prescribing of Controlled Substances Mintz
Oct
17
2022
California's New Law Prohibits Discrimination Against Employees For Off-The-Clock Use Of Cannabis Mintz
Jul
23
2015
Biosimilars, the BPCIA, and Amgen v. Sandoz: The Federal Circuit’s First Attempt To Make Sense of “A Riddle Wrapped in a Mystery Inside an Enigma” Mintz
Aug
5
2015
UPS Deal Continues Trend of Corporate Biofuel Commitments Mintz
Sep
30
2019
Patenting Considerations for Artificial Intelligence in Biotech and Synthetic Biology Mintz
Sep
17
2015
FDA Releases Two Final Food Safety Rules: What You Need to Know Mintz
Oct
12
2015
FDA Releases First Wholesaler and 3PL Facility Licensure Data to the Public Mintz
Nov
6
2015
Mylan Agrees to Divest Seven Products, Including Three Pipeline Products, to Clear FTC Hurdle in Its $27 Billion Tender Offer Bid for Perrigo Mintz
Nov
7
2019
FDA Issues Drug Shortage Report Identifying Root Causes and Potential Solutions Mintz
Nov
16
2015
Three More Food Safety Modernization Act Rules Finalized As Year Comes to Close Mintz
Mar
16
2023
AG Garland Signals That Department of Justice's Cannabis Policy Will Be "Very Close" To Cole Memorandum Mintz
Dec
17
2015
What Does Grocery Manufacturers Association’s SmartLabel Initiative Mean for False Advertising Litigation? Mintz
Dec
17
2019
New Revised USMCA Trade Deal Affects Intellectual Property Rights, But Not Exclusivity Period For Biologics Mintz
Jun
9
2023
FTC and DOJ Antitrust Memorialize Joint Workshop on the Future of Antitrust Enforcement in the Pharmaceutical Industry Mintz
Mar
22
2016
Lawsuits Against Honest Company Highlight Continued Risks of “All Natural” Labeling Mintz
Jun
20
2023
Effective July 1, Florida Will Prohibit Offshore Storage of Health Records and Require Additional Ownership Disclosures Mintz
Jul
12
2016
FDA Comes Through on Promise to Release NGS Device Draft Guidelines Expeditiously Mintz
Sep
20
2023
Mintz IRA Update — Other Key IRA Programs and Developments: The Medicare Prescription Drug Inflation Rebate Program and Maximum Monthly Cap on Cost-Sharing Payments Program Mintz
Nov
13
2023
FDA Delays Enforcement of MoCRA Facility Registration and Cosmetic Product Listing Requirements Mintz
Sep
26
2016
Review of International Regulation of Social Media Promotions at the 2016 RAPS Conference Mintz
Jan
8
2024
HHS, ONC HTI-1 Final Rule Introduces New Transparency Requirements for Artificial Intelligence in Certified Health IT Mintz
Aug
19
2020
Bioethics in a Pandemic: Vaccine Distribution Mintz
Oct
20
2020
Life Sciences Newsletter — October 2020 Mintz
Mar
21
2017
Wyden’s C-THRU Act – Publicizing PBM Drug Rebate Data Mintz
Dec
23
2020
FDA in 2020: What a Year! (Part 3 of 3) Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins